Beyond Complement: A Novel FAS Inhibition Approach for Neuroprotection in GA

Related

• 

  Impact of Baseline Imbalances on the Efficacy of Pegcetacoplan for the Treatment of GA: A Post Hoc Analysis of OAKS, DERBY, and FILLY

  Sunir J. Garg, MD, FACS, FASRS

  Updates from the Field

  2022

• 

  Expert Panel: Socioeconomics

  Linda A. Lam, MD, MBA, FASRS

  Ella H Leung, MD

  Mohsin H. Ali, MD

  Hasenin Al-khersan, MD

  Miguel A. Busquets, MD, FACS

  Annual Meeting Talks

  2024

• 

  Learnings From the Lampalizumab Chroma and Spectri Phase 3 Trials: Effect of Baseline Characteristics on Geographic Atrophy Progression

  Carl D. Regillo, MD

  Annual Meeting Talks

  2018